Allen Hicks is a trusted advisor that helps his clients navigate complex corporate transactions, public company securities requirements, and corporate governance challenges. He draws upon a diverse skill set developed through years of experience with a broad range of companies and industries to provide practical advice and insights for his clients.
He regularly advises public companies on Securities and Exchange Commission (SEC) reporting and disclosure obligations, stock exchange listing requirements, board and shareholder matters, capital markets offerings of equity and debt, and strategic transactions such as mergers and acquisitions (M&A), stock and asset purchases, divestitures, tender offers, and reorganizations.
Over his career, he has represented clients in the U.S. and internationally across various industry sectors, including aerospace, defense, and government services (ADG), life sciences, healthcare, financial services, hotel and lodging, real estate investment trusts (REITs), and technology. His clients range from large, global corporations to middle-market and emerging growth companies to nonprofit organizations.
Before joining the firm, Allen served as Chief Counsel to U.S. Senate Majority Leader William H. Frist. Utilizing this federal government experience, Allen also advises clients from time to time on legislative and policy issues before the U.S. Congress.
Areas of Focus
Represented General Electric (NYSE: GE) Capital in the US$9bn sale of its healthcare financial services business to Capital One.
Represented Lockheed Martin Corporation (NYSE: LMT) in multiple strategic acquisitions and more than US$11bn in debt securities offerings.
Represented REIT American Homes 4 Rent (NYSE: AMH) in more than US$1.3bn of common and preferred stock offerings, including a US$880m IPO.
Represented Laboratory Corporation of America (NYSE: LH) in multiple strategic acquisitions valued at more than US$1.3bn.
Represented Martek Biosciences Corporation (NASDAQ: MATK) in its US$1.1bn cross-border sale to Royal DSM, N.V.
Represented biotechnology company TESARO (NASDAQ: TSRO) in a US$201m convertible debt offering.
Represented Dun & Bradstreet Corporation (NYSE: DNB) in a US$125m acquisition of a marketing data technology company.
Represented a nonprofit U.S. foundation in a reorganization of its holdings in a hotel and residential real estate resort development in Costa Rica.